Clinical Trial Update: Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC [EARLY_Phase 1]

View source ↗

Summary

An early-phase expanded-access protocol evaluating CD3+/CD19+ depleted peripheral blood stem cells for leukemia and related immunodeficiency/metabolic condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Syndromes
• Immunodeficiency
• Immunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome
• Inborn Errors of Metabolism
• Leukemia

Drugs mentioned

• CD3+/CD19+ depleted peripheral blood stem cells

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Leukemia, Inborn Errors of Metabolism | EARLY_Phase 1 | Status: RECRUITING